These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25891106)

  • 1. Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents.
    Mishra RC; Gundala SR; Karna P; Lopus M; Gupta KK; Nagaraju M; Hamelberg D; Tandon V; Panda D; Reid MD; Aneja R
    Bioorg Med Chem Lett; 2015; 25(10):2133-40. PubMed ID: 25891106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.
    Mishra RC; Karna P; Gundala SR; Pannu V; Stanton RA; Gupta KK; Robinson MH; Lopus M; Wilson L; Henary M; Aneja R
    Biochem Pharmacol; 2011 Jul; 82(2):110-21. PubMed ID: 21501599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.
    Zhou J; Gupta K; Aggarwal S; Aneja R; Chandra R; Panda D; Joshi HC
    Mol Pharmacol; 2003 Apr; 63(4):799-807. PubMed ID: 12644580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
    Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
    J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design, synthesis, and biological evaluation of third generation α-noscapine analogues as potent tubulin binding anti-cancer agents.
    Manchukonda NK; Naik PK; Santoshi S; Lopus M; Joseph S; Sridhar B; Kantevari S
    PLoS One; 2013; 8(10):e77970. PubMed ID: 24205049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity.
    Henary M; Narayana L; Ahad S; Gundala SR; Mukkavilli R; Sharma V; Owens EA; Yadav Y; Nagaraju M; Hamelberg D; Tandon V; Panda D; Aneja R
    Biochem Pharmacol; 2014 Nov; 92(2):192-205. PubMed ID: 25124704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cells.
    Dash SG; Kantevari S; Pandey SK; Naik PK
    Chem Biol Drug Des; 2021 Sep; 98(3):466-479. PubMed ID: 34107169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of acetylation and bundling of cellular microtubules by 9-(4-vinylphenyl) noscapine elicits S-phase arrest in MDA-MB-231 cells.
    Cheriyamundath S; Mahaddalkar T; Kantevari S; Lopus M
    Biomed Pharmacother; 2017 Feb; 86():74-80. PubMed ID: 27939522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation.
    Ghaly PE; Abou El-Magd RM; Churchill CD; Tuszynski JA; West FG
    Oncotarget; 2016 Jun; 7(26):40518-40530. PubMed ID: 27777381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids.
    Santoshi S; Naik PK; Joshi HC
    J Biomol Screen; 2011 Oct; 16(9):1047-58. PubMed ID: 21972248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.
    Aneja R; Vangapandu SN; Lopus M; Chandra R; Panda D; Joshi HC
    Mol Pharmacol; 2006 Jun; 69(6):1801-9. PubMed ID: 16517755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of noscapine analogues as microtubule-interfering agents.
    Dai HL; Zheng JB; Lin M; Zheng J; Zhou FS; Dong XC; Guo L; Liu JW; Wen R
    Yao Xue Xue Bao; 2012 Oct; 47(10):1347-57. PubMed ID: 23289148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
    Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
    Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel and improved antimitotic agents derived from noscapine.
    Anderson JT; Ting AE; Boozer S; Brunden KR; Crumrine C; Danzig J; Dent T; Faga L; Harrington JJ; Hodnick WF; Murphy SM; Pawlowski G; Perry R; Raber A; Rundlett SE; Stricker-Krongrad A; Wang J; Bennani YL
    J Med Chem; 2005 Nov; 48(23):7096-8. PubMed ID: 16279766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
    Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
    J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
    Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
    J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the Tubulin-Targeted Anticancer Potential of Noscapine and its Structural Analogs.
    Kumar S; Sagar B; Gaur A; Shukla S; Pandey E; Gulati S
    Anticancer Agents Med Chem; 2023; 23(6):624-641. PubMed ID: 35927808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noscapinoids bearing silver nanocrystals augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in B16F1, mouse melanoma skin cancer cells.
    Soni N; Jyoti K; Jain UK; Katyal A; Chandra R; Madan J
    Biomed Pharmacother; 2017 Jun; 90():906-913. PubMed ID: 28441716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Class of N-Sulfonyl and N-Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer Cells.
    Yong C; Devine SM; Gao X; Yan A; Callaghan R; Capuano B; Scammells PJ
    ChemMedChem; 2019 Dec; 14(23):1968-1981. PubMed ID: 31714012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.